All In MedTech

Device Trial Radar · NCT01957787

Study of Cryoablation for Metastatic Lung Tumors

Multicenter Study of Metastatic Lung Tumors Targeted by Interventional Cryoablation Evaluation

Last checked: Nov 19, 2026Latest source record: Jul 19, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

131

Actual

Start

Apr 10, 2014

Primary completion

Mar 9, 2017

Study completion Aug 20, 2018

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Oct 8, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and efficacy of cryoablation therapy used to treat tumors in participants with pulmonary metastatic disease. This study is to enroll participants who will undergo cryoablation of at least 1 metastatic pulmonary tumor that is less than or equal to 3.5 centimeter (cm). Participants will be followed 24 months post their cryoablation procedure.

Conditions

  • Neoplasm Metastasis

Interventions

  • CryoablationDevice

    Application of extremely cold temperatures to the identified tumor(s).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Local Tumor Control for Each Index Tumor as Measured by Imaging at Month 12Time frame: Month 1 (Month 3 if Month 1 Data was missing) and Month 12

Locations

10 sites in 2 countries. Site status is shown where the registry gives one.

  • UCLA Ronald Reagan Medical Center

    Los Angeles, California

  • Cancer Treatment Centers of America at Southeastern Regional Medical Center

    Newnan, Georgia

  • Mayo Clinic Rochester

    Rochester, Minnesota

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.